Ruxolitinib Phosphate | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Ruxolitinib Phosphate
Canada

TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

Contact Supplier

Your reliable CDMO partner - agile, scalable, top-quality Small Molecule API & HPAPI solutions from concept to market

Contact Supplier

Ruxolitinib Phosphate

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Contact Supplier

pharmacompass-2-m-2025-11-03

Ruxolitinib Phosphate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

61 API Suppliers, 17 USDMF, 4 EU WC, 5 KDMF, 17 NDC API, 36 Listed Suppliers, $ API Reference Price

61 API Suppliers
17 USDMF
4 EU WC
5 KDMF
17 NDC API
36 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

260 Drugs in Development

260 Drugs in Development

INTERMEDIATES

34 Intermediate Suppliers

34 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

60 FDF Dossiers, 6 FDA Orange Book, 20 Europe, 5 Canada, 22 Australia, 3 South Africa, 4 Listed Dossiers

60 FDF Dossiers
6 FDA Orange Book
20 Europe
5 Canada
22 Australia
3 South Africa
4 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 1 DKSH, 1 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 9 BASF, 5 DFE Pharma, 5 Gangwal Chemicals, 1 Ideal Cures, 1 Ingredion Pharma Solutions, 10 Kerry, 2 Keval Exports, 10 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 1 Novo Excipients, 3 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 9 Roquette, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 3 Silverline Chemicals, 3 Vasa Pharmachem

1 SPI Pharma
1 DKSH
1 Boai NKY Pharmaceuticals Ltd
4 Gangwal Healthcare
1 Nanjing Well Pharmaceutical
4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
1 Ashland
9 BASF
5 DFE Pharma
5 Gangwal Chemicals
1 Ideal Cures
1 Ingredion Pharma Solutions
10 Kerry
2 Keval Exports
10 Microlex e.U
2 Nitika Pharmaceutical Specialities
1 Novo Excipients
3 Pharmatrans-Sanaq
3 Pluviaendo
3 Prachin Chemical
9 Roquette
2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
9 Sigachi Industries
3 Silverline Chemicals
3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

34 Fillers, Diluents & Binders, 17 Granulation, 15 Direct Compression, 14 Disintegrants & Superdisintegrants, 11 Lubricants & Glidants, 11 Thickeners and Stabilizers, 8 Co-Processed Excipients, 6 Solubilizers, 6 Controlled & Modified Release, 3 Coating Systems & Additives, 3 Parenteral, 3 Emulsifying Agents, 3 Chewable & Orodispersible Aids, 2 Film Formers & Plasticizers, 2 Taste Masking, 1 API Stability Enhancers, 1 Rheology Modifiers

34 Fillers, Diluents & Binders
17 Granulation
15 Direct Compression
14 Disintegrants & Superdisintegrants
11 Lubricants & Glidants
11 Thickeners and Stabilizers
8 Co-Processed Excipients
6 Solubilizers
6 Controlled & Modified Release
3 Coating Systems & Additives
3 Parenteral
3 Emulsifying Agents
3 Chewable & Orodispersible Aids
2 Film Formers & Plasticizers
2 Taste Masking
1 API Stability Enhancers
1 Rheology Modifiers

DIGITAL CONTENT

4 Data Compilation #PharmaFlow, 157 News #PharmaBuzz

4 Data Compilation #PharmaFlow
157 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 3 Regulatory FDF Prices, 11 Annual Reports

2 US Medicaid Prescriptions
3 Regulatory FDF Prices
11 Annual Reports

MARKET PLACE

25 APIs, 3 FDF Dossiers

25 APIs
3 FDF Dossiers

PATENTS & EXCLUSIVITIES

181 US Patents, 38 US Exclusivities, 11 Health Canada Patents

181 US Patents
38 US Exclusivities
11 Health Canada Patents

$ API Ref.Price (USD/KG) : 25,173 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

5 All

01 1INCYTE CORPORATION

02 4NOVARTIS PHARMACEUTICALS CANADA INC

filter Active Ingredients Reset all filters

5 All

01 5RUXOLITINIB (RUXOLITINIB PHOSPHATE)

filter Dosage Form Reset all filters

5 All

01 1CREAM

02 4TABLET

filter Brand Name Reset all filters

5 All

01 4JAKAVI

02 1OPZELURA

List of Suppliers

Product Main Page

01

INCYTE CORPORATION

CPhI India

Not Confirmed

INCYTE CORPORATION

CPhI India

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

RUXOLITINIB (RUXOLITINIB PHOSPHATE)

Brand Name : OPZELURA

Dosage Form : CREAM

Dosage Strength : 1.5%/W/W

Packaging :

Approval Date :

Application Number : 2552434

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

NOVARTIS PHARMACEUTICALS CANADA INC

CPhI India

Not Confirmed

NOVARTIS PHARMACEUTICALS CANADA INC

CPhI India

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

RUXOLITINIB (RUXOLITINIB PHOSPHATE)

Brand Name : JAKAVI

Dosage Form : TABLET

Dosage Strength : 5MG

Packaging : 56/60

Approval Date :

Application Number : 2388006

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

NOVARTIS PHARMACEUTICALS CANADA INC

CPhI India

Not Confirmed

NOVARTIS PHARMACEUTICALS CANADA INC

CPhI India

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

RUXOLITINIB (RUXOLITINIB PHOSPHATE)

Brand Name : JAKAVI

Dosage Form : TABLET

Dosage Strength : 15MG

Packaging : 56/60

Approval Date :

Application Number : 2388014

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

NOVARTIS PHARMACEUTICALS CANADA INC

CPhI India

Not Confirmed

NOVARTIS PHARMACEUTICALS CANADA INC

CPhI India

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

RUXOLITINIB (RUXOLITINIB PHOSPHATE)

Brand Name : JAKAVI

Dosage Form : TABLET

Dosage Strength : 20MG

Packaging : 56/60

Approval Date :

Application Number : 2388022

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

NOVARTIS PHARMACEUTICALS CANADA INC

CPhI India

Not Confirmed

NOVARTIS PHARMACEUTICALS CANADA INC

CPhI India

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

RUXOLITINIB (RUXOLITINIB PHOSPHATE)

Brand Name : JAKAVI

Dosage Form : TABLET

Dosage Strength : 10MG

Packaging : 4X14/60

Approval Date :

Application Number : 2434814

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!